news Scmp World 2026-11-07

FDA probes potential tumor risks associated with Novartis gene therapy Zolgensma

The US Food and Drug Administration is investigating reports of tumor formation in children treated with Novartis' spinal muscular atrophy drug, Zolgensma.

Support Your Local Toad

The Pesky Toad is free and ad-light. If you find it useful, toss a few pesos in the tip jar to help keep the servers running and the satire flowing.

$

MXN · Minimum $10